Used in biomedical research to quantify levels of isocitrate dehydrogenase 1 (IDH1) in human samples such as serum, plasma, or tissue lysates. This ELISA kit enables detection of IDH1 protein expression, supporting studies on metabolic disorders, cancer progression, and neurodegenerative diseases where IDH1 mutations or dysregulation play a role. Commonly applied in oncology research, particularly in glioma and acute myeloid leukemia studies, to assess mutant IDH1 as a biomarker for diagnosis, prognosis, or therapeutic response. The assay provides a sensitive and specific means to monitor changes in IDH1 levels in experimental models and clinical investigations.